Summary
GE HealthCare Technologies Inc. (GEHC) announced on December 1, 2025, the successful pricing of a significant debt offering totaling $1.25 billion. The offering comprises $600 million in 4.150% Notes due December 15, 2028, and $650 million in 4.950% Notes due December 15, 2035. This move indicates the company's strategy to access capital markets, likely to fund ongoing operations, strategic initiatives, or refinance existing debt. Investors should note the coupon rates, which reflect current market interest rates and the company's credit profile at the time of issuance.
Key Highlights
- 1GE HealthCare priced a $1.25 billion debt offering on December 1, 2025.
- 2The offering includes $600 million of 4.150% Notes due 2028.
- 3The offering also includes $650 million of 4.950% Notes due 2035.
- 4The Notes are expected to close on or around December 15, 2025.
- 5The offering was conducted under a previously filed Form S-3 registration statement.
- 6Goldman Sachs & Co. LLC and BNP Paribas Securities Corp. acted as underwriters.
Frequently Asked Questions
While the specific use of proceeds is not detailed in this 8-K filing, such offerings are typically used to fund general corporate purposes, which can include capital expenditures, strategic acquisitions, research and development, or refinancing existing debt obligations.
The offering consists of $600 million of 4.150% Notes due December 15, 2028, and $650 million of 4.950% Notes due December 15, 2035.
The Notes are expected to be issued on or around December 15, 2025, subject to customary closing conditions.
The Underwriting Agreement outlines the terms and conditions under which the underwriters (Goldman Sachs & Co. LLC and BNP Paribas Securities Corp.) have agreed to purchase the Notes from GE HealthCare. It details responsibilities, representations, and covenants related to the offering.